Published: Fri, November 23, 2018
Health Care | By Cedric Leonard

Insulin Injection Shortage Get Worse with Increase of Type 2 Diabetes

Insulin Injection Shortage Get Worse with Increase of Type 2 Diabetes

As the number of people with diabetes soars, the growing demand for insulin will result in a shortfall for the drug, CNN has reported, citing findings from a new study.

The rate at which people are developing diabetes has experts anxious that we will not be able to keep up with the demand for insulin.

Their study, funded by the Helmsley Charitable Trust, was based on projections of diabetes prevalence from the International Diabetes Federation. Half of these people would come from China (130 million), India (98 million), and the US (32 million).

Half of those would come from China, India and the US.

The researchers conclude in the journal The Lancet that of all these diabetes patients, 79 million would actually be in need of insulin to manage their diabetes.

But a study showcases that 79 million people with Type 2 will need it by 2030, and around half of them may not get access to it.

Venus Williams Reaches Settlement In Fatal Traffic Accident
Barson, who was a passenger in a sedan that collided with the SUV that Williams was driving, died 13 days after the accident. Barson died almost two weeks after the crash but neither driver was charged as police said both had right of way.


Insulin is essential for all people with type 1 diabetes and some people with type 2 diabetes to reduce the risk of complications such as blindness, amputation, kidney failure, and stroke, researchers said.

Editor's note: Eating a healthy diet low in carbohydrate, sugar and processed food can help to lower blood glucose levels, and people with type 2 diabetes have been able to put the condition into remission, coming off all their diabetes medication, by following a healthy eating plan.

By measuring the expected increase in insulin demand by 2030 and the incidence of type 2 diabetes, it signaled grave dearth of insulin to treat the patients.

"Unless governments begin initiatives to make insulin available and affordable, then its use is always going to be far from optimal", said Basu. The issue is amplified by the fact that the treatment for diabetes is also highly costly - something that may be driven by business interests rather than free market forces. In the United States in particular, the cost of insulin has soared over the past decade, almost tripling in cost from 2002-2013.

The situation is being made worse due to the fact there are only three major manufacturers of insulin: Novo Nordisk, Sanofi and Lilly. Around 33 million people who require insulin presently have no acquisition to the drug.

Like this: